ArticleAesthetic surgery journal. Open forum2026
All About Clonidine and Its Role in Preventing Hematoma Following Aesthetic Facial Surgery: A Narrative Review With Practical Guidance.
Article in Aesthetic surgery journal. Open forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postoperative hematoma remains the most common major complication following face and necklift surgery, with decades of literature highlighting perioperative hypertension and sympathetic surges as primary modifiable risk factors. Clonidine, a centrally acting alpha-2 adrenergic agonist, has been progressively incorporated into facelift protocols to stabilize postoperative blood pressure and blunt sympathetic activation. This narrative review examines the pharmacology of clonidine, the pathophysiology of postfacelift bleeding, and the clinical evidence supporting clonidine's role in perioperative blood pressure management. Practical dosing strategies, contraindications, and safety considerations are presented based on the available literature and the authors' clinical experience. When used in a comprehensive perioperative blood pressure management protocol, clonidine appears to be a safe and effective adjunct for hematoma prevention in aesthetic surgery, although the supporting evidence is predominantly Level IV (retrospective series and observational studies) supplemented by expert opinion. Practical dosing strategies, contraindications, and safety considerations are presented based on the available literature and the authors' clinical experience. Level of Evidence: 5 (Therapeutic) For image description, please refer to the figure legend and surrounding text.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.